Your browser doesn't support javascript.
loading
Advances in the mechanism of emodin-induced hepatotoxicity.
Wang, Yupeng; Zhao, Mengchao; Li, Bo; Geng, Xingchao.
Afiliação
  • Wang Y; National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control. Chinese Academy of Medical Sciences & Peking Union Medical College, 100050, China.
  • Zhao M; Department of Pharmacy, General Hospital of Ningxia Medical University, 804 Shengli Street, Xingqing District, Ningxia, 750004, China.
  • Li B; National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control. Chinese Academy of Medical Sciences & Peking Union Medical College, 100050, China.
  • Geng X; National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control. Chinese Academy of Medical Sciences & Peking Union Medical College, 100050, China.
Heliyon ; 10(13): e33631, 2024 Jul 15.
Article em En | MEDLINE | ID: mdl-39027614
ABSTRACT
Emodin is a naturally occurring anthraquinone derivative and serves as an active component in various traditional Chinese herbal medicines. It is widely known for its broad pharmacological effects, including anti-inflammatory, antioxidant, and anticancer properties. However, high doses and long-term use of emodin can also lead to liver toxicity. Nevertheless, the mechanism of emodin-induced liver toxicity remains unclear at present. This article aims to summarize the toxicological research progress on emodin, with a particular focus on elucidating the mechanisms underlying emodin-induced hepatocyte injury. By providing essential information, the study intends to facilitate further research and safe usage of emodin for researchers and clinical practitioners.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Heliyon Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Heliyon Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido